Alto Neuroscience Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Alto Neuroscience Inc 's ROA in the second quarter of 2026?
Alto Neuroscience Inc recorded a cumulative net loss of $-84 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -39.09%.

However, within the Healthcare sector 477 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3773, from total ROA ranking in the first quarter of 2026 at 4422.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	60.93 %	60.7 %	4.03 %	-23.28 %	-20.01 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-84	-74	-63	-62	-65
Return On Assets (TTM)	-39.09 %	-38.81 %	-38.24 %	-38.06 %	-37.12 %
ANRO's Total Ranking	# 3773	# 4422	# 3879	# 3899	# 3925
Total Assets (TTM) in million	254	276	185	147	158
Seq. Total Assets Change	-8.03 %	49.58 %	25.63 %	-6.89 %	-8.17 %
Seq. Net Income Change	-	-	-	-	-

ANRO's 5 Years Annual ROA >> Back to ANRO Management Effectiveness >> Compare ANRO ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 189
Sector	# 478
Overall	# 3741

Return On Assets Statistics
High	Average	Low
-31.65 %	-36.74 %	-39.09 %
(Dec 31 2024)		(Jun 30 2026)

Financial Statements
Alto Neuroscience Inc 's Assets	$ 254 million	ANRO's Balance sheet
Alto Neuroscience Inc 's Income	$ -28 million	Quarterly ANRO's Income Statement
ANRO's Income by Division		See ANRO's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	FY	FY	FY
Y / Y Total Assets Change	4.03 %	-	-	-	-
Total Assets in million	185	178	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-63	-61	0	0	0
Annual Return On Assets	-34.24 %	-34.6 %	-	-	-

ANRO's 5 Years Annual ROA >> Back to ANRO Management Effectiveness >> Compare ANRO ROA to its Competitors

More Return On Assets Ratios
ANRO's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ANRO's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ANRO's Competitors
Subscribers only: Roa for Alto Neuroscience Inc 's Suppliers
Subscribers only: Return On Assets for ANRO's Customers

You may also want to know
ANRO's Roi	ANRO's Inventory Turnover Ratio	ANRO's Growth Rates	ANRO's Dividend Comparisons
	ANRO's Profitability Ratios	ANRO's Asset Turnover Ratio	ANRO's Dividend Growth
ANRO's Roe	ANRO's Valuation Ratios	ANRO's Financial Strength Ratios	ANRO's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-03T11:30:27+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.